| Name | Title | Contact Details |
|---|---|---|
David Steinberg |
Chief Financial Officer | Profile |
Adam Sun |
Vice President, Research & Development | Profile |
Ice Biotech, Inc. is a Dundas, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
QSpex embodies the ideal to provide its capital partners best-in-class financial returns, and its customers distinguishable and meaningful value. We will deliver on these fundamentals, while delivering on a higher purpose, advancing the eco-system at-large. We will do this through an inspired vision, integrated ideals, an accountable organization and compassionate leadership.
Intellisphere is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Abramson Cancer Center of the University of Pennsylvania is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.